Interestingly, in low-grade tumors, we detected a significant difference in CD47 expression between tumor cells and TIIC in the periphery, with more than half of TIICs expressing CD47 as compared to tumor cells, Fig. 6. This evidence concerns the gene CD47 and neoplasm.